During the past decade, PHV Dialysezentrum Kiel conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "PHV Dialysezentrum Kiel" #1 collaborator was "Institut Dr. Schauerte (IDS)" with 1 trials as a collaborator, "Institut Dr. Schauerte GmbH (IDS)" with 1 trials as a collaborator and "Siro Clinpharm Germany GmbH" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "PHV Dialysezentrum Kiel" are "End Stage Renal Disease" (3 trials), "Renal Failure" (3 trials), "ESRD" (1 trials) and "Hyperphosphataemia" (1 trials). Many other conditions were trialed in "PHV Dialysezentrum Kiel" in a lesser frequency.

Most popular intervention types in "PHV Dialysezentrum Kiel" are "Device" (3 trials). Other intervention types were less common.

The name of intervention was led by "Dialyser" (2 trials) and "Dialyzer" (1 trials). Other intervention names were less common.

The vast majority of trials in "PHV Dialysezentrum Kiel" are 4 trials for "All" genders.

Currently, there are NaN active trials in "PHV Dialysezentrum Kiel". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in PHV Dialysezentrum Kiel, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in PHV Dialysezentrum Kiel, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".